Metformin improves the survival rate of the lethal endotoxemia mouse model via inhibiting the release of HMGB1. AMPK activation is one of the mechanisms causing HMGB1 secretion inhibition (118). The gene discussed is PRKAA1; the disease is serum lipopolysaccharide activity.